The history of bone-marrow transplantation

Blood Reviews

Volumn 10, Issue 4, 1996, Pages 215-219

  Perry, A R ^a   Linch, D C ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; GRAFT REJECTION; HEMATOLOGIC DISEASE; HISTORY OF MEDICINE; HLA MATCHING; HUMAN; PRIORITY JOURNAL; RADIATION CHIMERA;

EID: 0030454865     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(96)90004-1     Document Type: Conference Paper

References (73)

1. Jacobson LO, Marks EK, Robson MJ, Gaston EO, Zirkle RE. Effect of spleen protection on mortality following x-irradiation. J Lab Clin Med 1949; 34: 1538-1543.
2. Jacobson LO, Simmons EL. Marks EK, Eldredge JH. Recovery from radiation injury. Science 1951; 113: 510.
3. Lorenz E, Uphoff D, Reid TR, Shelton E. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 1951; 12: 197-201.
4. Main JM, Prehn RT. Successful skin homografts after the administration of high dosage X irradiation and homologous bone marrow. J Natl Cancer Inst 1955; 115: 1023-1029.
5. Barnes DWH, Ilbery PLT, Loutit JF. Avoidance of 'secondary disease' in radiation chimeras. Nature 1958; 181: 488.
6. Nowell PC, Cole LJ, Habermeyer JG, Roan PL. Growth and continued function of rat marrow cells in x-irradiated mice. Cancer Res 1956; 258-261.
7. Lindsley DI, Odell TT, Tausche FG. Implantation of functional erythropoietic elements following total body irradiation. Proc Soc Exp Biol Med 1955; 90: 512-515.
8. Mitchison NA. The colonisation of irradiated tissue by transplanted spleen cells. Br J Exp Path 1956; 37: 239-247.
9. Ford CE, Hammerton JL, Barnes DWH, Loutit JF. Cytological identification of radiation chimeras. Nature 1956; 177: 452-454.
10. Mathe G, Jammet H, Pendic B et al. Transfusions et greffes de moelle osseuse homologue chez des humains irradiés á haute dause accidentellement. Rev Fran Etudes Et Biologiques 1959; 4: 226-238.
11. Thomas ED, Ferrebee JW. Transplantation of marrow and whole organs: experiences and comments. The Can Med Ass Journ 1962; 86: 435-444.
12. Beilby JO, Cade IS, Jeliffe AM, Parkin DM, Stewart JW. Prolonged survival of a bone-marrow graft resulting in a blood group chimera. BMJ 1960; i: 96-99.
13. Thomas ED, Ferrebee JW. Irradiation and marrow transplantation: studies in Cooperstown. Lancet 1960; 1289-1290.
14. Thomas ED, Ashley CA, Lochte HI et al. Homografts of bone marrow in dogs after lethal total body irradiation. Blood 1959; 14: 720-736.
15. Thomas ED, Lochte BL, Ferrebee JW. Irradiation of the entire body and marrow transplantation: some observations and comments. Blood 1959; 14: 1-23.
16. Thomas ED. Bone marrow transplantation in man. Diagnosis and treatment of acute radiation injury. Geneva: WHO, 1961: 273-288.
17. Gorer RA. The genetic and antigenic basis of tumour transplantation. J Path Bact 1937; 44: 691-697.
18. Woodruff MFA. The transplantation of tissues and organs. Springfield, II: Charles C Thomas, 1960.
19. Schwartz R, Dameshek W. Drug-induced immunological tolerance. Nature 1959; 183: 1682-1683.
20. Elion GB, Callahan S, Bieber S, Hitchings GH, Rundles RW. A summary of investigations with 6-thiopurine. Cancer Chemother Rep 1961; 14: 93-98.
21. Murray JE. The first successful organ transplants in man. In: Frangsmur T, Lundeberg B, eds. The Nobel Prizes. Stockholm: Norstedts Tryckers AB, 1992: 204-214.
22. Ferrebee JW, Thomas ED. The restoration of hematopoiesis following lethal exposure to radiation. Trans Ass Am Phy 1959; Ixxii: 284-292.
23. Congdon CC, Urso IS. Homologous bone marrow in the treatment of radiation injury to mice. Am J Path 1957; 33: 749.
24. Barnes DW, Loutit JF, Micklem HS. 'Secondary disease' of radiation chimeras: a syndrome due to lymphoid aplasia. Ann NY Acad Sci 1962; 99: 374-385.
25. Barnes DWH, Loutit JF. Spleen protection: the cellular hypothesis. In: Radiobiology Symposium, Liege. London: Butterworths, 1955: 134-135.
26. Mathe G, Amiel JL, Schwartzenberg L et al. Haematopoietic chimera in man after allogeneic bone marrow transplantation (control of secondary symptoms, specific tolerance due to chimerism). B Med J 1963; 2: 1633-1635.
27. Santos GW, Cole LJ. Effect of donor and host lymphoid and myeloid tissue injections in lethally x-irradiated mice treated with rat bone marrow. J Natl Cancer Inst 1958; 21: 279-293.
28. Van Bekkum DW, DeVries JJ. Radiation chimeras. London: Logos 1967: 277.
29. Billingham RE, Silvers WK. Some factors that determine the ability of cellular inocula to induce tolerance of tissue homografts. J Cell Comp Phys 1962; 60(S1): 183-200.
30. Owens AH, Santos GW. The induction of graft-versus-host disease in mice treated with cyclophosphamide. J Exp Med 1968; 128: 277-291.
31. Gowans JL. The fate of parental strain small lymphocytes in FI hybrid rats. Ann NY Acad Sci 1962; 99: 432-455.
32. Medawar PB. Introduction: definition of the immunologically competent cell. Ciba Found Study Group 1963; 16: 1-5.
33. Trentin JJ. Mortality and skin transplantability in x-irradiated mice receiving isologous homologous or heterologous bone marrow. Proc Soc Exp Biol Med 1956; 92: 688.
34. Billingham RE. The biology of graft-versus-host reactions. Harvey Lectures 1966-67; 62: 21-78.
35. Uphoff DE. The preclusion of secondary phase of the irradiation syndrome by inoculation of fetal haematopoietic tissue following lethal total body irradiation. J Natl Cancer Inst 1958; 20: 625.
36. Storb R, Epstein RB, Graham TC, Thomas ED. Methotrexate regimens for control of graft versus host disease in dogs with allogeneic marrow grafts. Transplantation 1970; 9: 240-246.
37. Thomas ED, Collins JA, Herman EC, Ferrebee JW. Marrow transplants in lethally irradiated dogs given methotrexate. Blood 1962; 19: 217-228.
38. Pegg DE. Allogeneic bone marrow transplantation in man. In: Bone Marrow Transplantation London: Lloyd-Luke Medical Books, 1966: 77-101.
39. Daussett J, Rapaport FT, Ivanyi P, Colombani J. Tissue alloantigens and transplantation In: Balner H, Cleton FJ, Eernisse JG, eds. Histocompatibility Testing? Copenhagen: Munksgaard, 63-67.
40. Payne R, Tripp M, Weigle J et al. A new leucocyte isoantigen system in man. Cold Spring Harb Symp Quant Biol 1964; 29: 285-295.
41. Van Rood JJ, Eernisse JG, Van Leeuwen A. Leucocyte antibodies in serum from pregnant women. Nature 1958; 181: 1735-1736.
42. Thomas ED. History of Bone Marrow Transplantation. The International Autologous Bone Marrow Transplantation Registry Newsletter 1993; 7.
43. Graw RG, Lohrmann HP, Bull MI et al. Bone marrow transplantation following combination chemotherapy immunosuppression in patients with acute leukaemia. Transpl Proc 1974; 6: 349-354.
44. Thomas ED, Lochte HI Jr, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 1957; 257: 491-496.
45. Hickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148: 871-875.
46. Powles RL, Clink FW, Spence D et al. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone marrow transplantation. Lancet 1980; 1: 327-329.
47. Deeg HJ, Storb R, Weiden PL et al. Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host-disease and induction of tolerance. Transplantation 1982; 34: 30-35.
48. Deeg HJ, Storb R, Applebaum FR, Kennedy MS, Graham TC, Thomas ED. Combined immunosuppression with Cyclosporin and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates. Transplantation 1984; 37: 62-65.
49. Buckner CD, Applebaum FR, Thomas ED. Bone marrow and fetal liver. In: Karon AM Jr, Pegg DE, eds. Organ Preservation for Transplantation. New York: Marcel Dekker, 1981: 355-375.
50. Thomas ED, Buckner CD, Clift RA et al. Marrow transplantation for acute nonlymphoblastic leukaemia in first remission. N Engl J Med 1979; 301: 597-599.
51. Santos GW. History of bone marrow transplantation. Clin Haematol 1983; 12: 611-639.
52. Barrett J. Worldwide bone marrow transplantation activity in the last decade. New strategies in bone marrow transplantation New York: Wiley-Liss, 1991: 1-6.
53. The Anthony Nolan Bone Marrow Trust. BPCC Oyez Press Ltd.
54. Mcfarland W, Granville NB, Dameshek W. Autologous bone marrow infusion as an adjunct in therapy of malignant disease. Blood 1959; 14: 503-521.
55. Pegg DE. Bone marrow transplantation. Chicago, IL: Year Book Medical Publishers 1966: 192.
56. Goldstone AH. Autologous bone marrow transplantation. Br J Haem 1984; 58: 1-7.
57. Appelbaum FR, Buckner CD. Overview of the clinical relevance of autologous bone marrow transplantation. Clin Haematol 1986; 15: 1-18.
58. Kessinger A, Armitage JO, Landmark JD et al. Autologous peripheral haematopoietic stem cell transplantation restores haematopoietic function following marrow ablative therapy. Blood 1988; 71: 723-727.
59. Armitage JO. Applications of autologous bone marrow transplantation for the treatment of cancer. Curr Opin Haematol 1993; 240-245.
60. Lucarelli G, Galimberti M, Polchi P et al. Bone marrow transplantation in patients with thalassaemia. N Engl J Med 1990; 322: 417-421.
61. Gluckman E, Berger R, Dutreix J. Bone marrow transplantation for Fanconi anaemia. Sem Haem 1984; 21: 20.
62. Karlsson S. Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 1991; 78: 2481-2492.
63. Gale RP. Cord-blood-cell transplantation - a real sleeper? N Engl J Med 1995; 332: 392-394.
64. Kumar L, Goldman JM. Bone marrow transplantation for patients lacking an HLA-identical sibling. Curr Opin Haematol 1993; 234-239.
65. Meyers JD, Thomas ED. Infection complicating bone marrow transplantation. In: Rubin H, Young LS. Clinical approach to infection in the immunocompromised host. New York: Plenum Press, 1988: 525-556.
66. Editorial. How can the results of bone marrow transplantation be improved? Bone Marrow Transplant 1988; 3: 1.
67. Butturini A, Gale RP. T cell depletion in bone marrow transplantation for leukaemia: current results and future directions. Bone Marrow Transplant 1988; 3: 185.
68. Barnes DWH, Corp MJ, Loutit JF, Neal FE. Treatment of murine leukaemia with X rays and homologous bone marrow. Preliminary communication. Br Med J 1956; 2: 626.
69. Antin JH. Graft versus leukaemia: no longer an epiphenomenon. Blood 1993; 8: 2273-2277.
70. Horowitz MM, Gale RP, Sondel P, Goldman JM et al. Graft-versus-leukaemia reactions after bone marrow transplantation. Blood 1990; 3: 555-562.
71. Gale RP, Champlin RE. How does bone marrow transplantation cure leukaemia? Lancet 1984; 2: 28-29.
72. Soiffer RJ, Murray C, Cochran K, Cameron C et al. Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell depleted allogeneic bone marrow transplantation. Blood 1992; 79: 517-526.
73. O'Reilly RJ, Mackinnon S, Kwak LW, Riddell SR. Allogeneic marrow transplants as adoptive immunotherapy: molecular and cellular interactions contributing transferable leukaemia resistance and viral immunity. Am Soc Hem Education Program 1995; 13: 101-111.